Finding the Right Fit in Ophthalmology Residency

Bradford L. Tannen, MD, JD, MBA; Daniel B. Moore, MD; Jackson Laureano, MD; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH

Eyetube

Blake K. Williamson, MD, MPH, and Gary Wörtz, MD, speak with Bradford Tannen, MD, JD, MBA; Daniel B. Moore, MD; and Jackson Laureano, MD, about ophthalmology residency training at the University of Kentucky. The group weighs what matters beyond a strong application, including authentic research interests, away rotations, and the interpersonal qualities that make someone a good resident. They also discuss early surgical experience, how operative volume builds confidence, and why finding the right fit may matter more than reputation alone.

Harnessing Ocular Physiology: Fast and Sustained Tear Production With TRYPTYR® (acoltremon ophthalmic solution) 0.003% for Dry Eye Disease

Data from the pivotal COMET clinical trials reveal how the first topical ocular neuromodulator approved for the signs and symptoms of DED, TRYPTYR®, delivers a rapid increase in natural tear production.

John Hovanesian, MD (Moderator)*; Marjan Farid, MD*; Nate Lighthizer, OD*; Selina McGee, OD*

Cataract and Refractive Surgery Today

Modified Implantation of Port Delivery System With Ranibizumab Without PPV or Endolaser

Levent Akduman, MD, and Lauren Pollack, BS

Eyetube

The speakers demonstrate a modified technique for implantation of the the port delivery system with ranibizumab (Susvimo, Genentech/Roche) performed without the use of pars plana vitrectomy or endolaser. To date, the speakers have performed 17 cases using this approach without complications attributable to these modifications. In their experience, the technique may reduce surgical time, intraocular manipulation, resource utilization, and cost, while maintaining favorable short-term surgical outcomes. Further cases and longer follow-up periods are needed to establish the safety and reproducibility of this approach.

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

A Potential Digital Co-Pilot in the Retina OR

AI systems may one day augment traditional surgical workflows to improve efficiency and patient outcomes.

Stanley Poh, MBBS, MMed (Ophth), FRCOphth, FAMS, and Daniel Ting, MD, PhD

Retina Today

KEY TAKEAWAYS By analyzing large volumes of data, AI could generate clinically meaningful insights to enable more informed decision making in the OR. AI could identify high-risk cases and flag factors such as suboptimal glycemic control, anticoagulant use, medical comorbidities, drug allergies, and mobility limitations. Agentic AI can act as a digital co-pilot by integrating preoperative, intraoperative, and postoperative capabilities. Vitreoretinal surgery is a complex discipline involving intricate and highly variable pathology. Many decisions depend on dynamic changes in anatomy and tissue behavior, surgical visualization, and potential complications. As such, vitreoretinal fellows face a steep learning curve. Years of training through residency, fellowship, and independent surgical practice are required to develop the judgement needed to determine whether surgery is warranted, which intervention is most appropriate, and how urgently it should be performed. As AI tools proliferate and improve, they could advance the evolution of the retina OR. By analyzing large volumes of clinical, imaging, and procedural data, AI could generate timely, clinically meaningful insights to enable more informed decision making across preoperative, intraoperative, and postoperative phases of care (Figure). In many ORs, digital visualization systems and intraoperative OCT have already broadened what surgeons can see and have influenced surgical decision making.

EyewireTV

11.04.2026

11.04.2026

Astellas Pharmaceuticals

Ocular Therapeutix

Genentech/Roche

Nanoscope Therapeutics

Regenxbio

4DMT

Kodiak Sciences

Optos

Annexon Biosciences

Beacon Therapeutics

Eyewire News

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001

Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States

AEYE Health Wins 2026 Prix Galien USA Award for Autonomous AI Diabetic Retinopathy Screening Technology

Stocks

Cataract

Refocusing the Patient Experience—AI and Team-Based Care in Ophthalmology

Complex Exchange

A Head-to-Head Study of Two Full Visual Range Lens Platforms

Ophthalmic Executives Provide Company Updates (Part 1 of 2)

Special Report: Potential of Robotic Cataract Surgery

SmartSight NOVA with CenTrax – Intelligent Centration and Eye Tracking for a New Standard of Precision

11.05.2026

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001

11.05.2026

Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States

11.03.2026

Zeiss Commits to Expanding Global Eye Care Access at IAPB Summit

11.03.2026

Moorfields Eye Hospital Appoints Aruna Mehta as New Chair

Refractive

Finding the Right Fit in Ophthalmology Residency

Refocusing the Patient Experience—AI and Team-Based Care in Ophthalmology

Harnessing Ocular Physiology: Fast and Sustained Tear Production With TRYPTYR® (acoltremon ophthalmic solution) 0.003% for Dry Eye Disease

Going on Offense With Epioxa

A New Era of Advanced IOLs

Kodiak Plans to Submit BLA for Zenkuda After Phase 3 Data

11.05.2026

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001

11.05.2026

Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States

11.03.2026

Moorfields Eye Hospital Appoints Aruna Mehta as New Chair

11.02.2026

Hundred Vision Launches Luma Eye-Tracking System to Assess Oculomotor and Binocular Visual Function

Stay Updated

Follow Eyewire News

Retina

Modified Implantation of Port Delivery System With Ranibizumab Without PPV or Endolaser

Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)

One to Watch: Douglas R. Matsunaga, MD

PPV vs Phacovitrectomy for RRD in Phakic Eyes

Stuff-In Free ILM Flap for Stubborn Macular Hole

Sub-ILM Hemorrhage in the Macula

11.05.2026

Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States

11.04.2026

AEYE Health Wins 2026 Prix Galien USA Award for Autonomous AI Diabetic Retinopathy Screening Technology

11.03.2026

Moorfields Eye Hospital Appoints Aruna Mehta as New Chair

11.03.2026

Harrow Launches HarrowRx Prescribing Platform to Streamline Ophthalmic Medication Access

Glaucoma

Breaking News From the AAO Annual Meeting in New Orleans (Part 1 of 2)

Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)

Special Report: Potential of Robotic Cataract Surgery

Ophthalmic Executives Provide Company Updates (Part 1 of 2)

Sustainability Recommendations for Glaucoma Practice

Refractive Considerations for Supraciliary Surgery

11.05.2026

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001

11.05.2026

Prism Vision Group Acquires Spectrum Vision Partners, Expanding Ophthalmology Network Across Five States

11.03.2026

Moorfields Eye Hospital Appoints Aruna Mehta as New Chair

11.03.2026

Harrow Launches HarrowRx Prescribing Platform to Streamline Ophthalmic Medication Access